Protein Polymer Technologies Receives FDA 510(K) Clearance For New Embolization Convenience Kits

Protein Polymer Technologies, Inc. (OTC BB: PPTI), a biotechnology device company that is a pioneer in protein design and synthesis, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its new convenience kits which are packaged with Surgica Corporation's proprietary foam embolization products. These three new convenience kits have been designed to offer improved ease of use and overall procedure efficiency for physicians in the field of Interventional Radiology.

Back to news